Enhancing insulin-use safety in hospitals

Practical recommendations from an ASHP Foundation expert consensus panel

Daniel J. Cobaugh, Gregory Maynard, Raymond Cooper, Patricia C. Kienle, Robert Vigersky, Diana Childers, Robert Weber, Stacy L. Carson, Melanie E. Mabrey, Nicki Roderman, Frederick Blum, Rebecca Burkholder, Marcus Dortch, George Grunberger, Daniel Hays, Rashida Henderson, Jeffrey Ketz, Todd Lemke, Surendra K. Varma, Michael Cohen

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Purpose. Consensus recommendations to help ensure safe insulin use in hospitalized patients are presented. Copyright

Summary. Insulin products are frequently involved in medication errors in hospitals, and insulin is classified as a high-alert medication when used in inpatient settings. In an initiative to promote safer insulin use, the American Society of Health-System Pharmacists (ASHP) Research and Education Foundation convened a 21-member panel representing the fields of pharmacy, medicine, and nursing and consumer advocacy groups for a three-stage consensus-building initiative. The panel's consensus recommendations include the following: development of protocol-driven insulin order sets, elimination of the routine use of correction/sliding-scale insulin doses for management of hyperglycemia, restrictions on the types of insulin products stored in patient care areas, and policies to restrict the preparation of insulin bolus doses and i.v. infusions to the pharmacy department. In addition, the panelists recommended that hospitals better coordinate insulin use with meal intake and glucose testing, prospectively monitor the coordination of insulin delivery and rates of hypoglycemia and hyperglycemia, and provide standardized education and competency assessment for all hospitalbased health care professionals responsible for insulin use.

Conclusion. A 21-member expert panel convened by the ASHP Foundation identified 10 recommendations for enhancing insulin-use safety across the medicationuse process in hospitals. Professional organizations, accrediting bodies, and consumer groups can play a critical role in the translation of these recommendations into practice. Rigorous research studies and program evaluations are needed to study the impact of implementation of these recommendations.

Original languageEnglish (US)
Pages (from-to)1404-1413
Number of pages10
JournalAmerican Journal of Health-System Pharmacy
Volume70
Issue number16
DOIs
StatePublished - Aug 15 2013

Fingerprint

Pharmacists
Insulin
Safety
Health
Hyperglycemia
Consumer Advocacy
Education
Medication Errors
Program Evaluation
Research
Hypoglycemia
Meals
Inpatients
Patient Care
Nursing
Medicine
Delivery of Health Care
Glucose

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Health Policy

Cite this

Enhancing insulin-use safety in hospitals : Practical recommendations from an ASHP Foundation expert consensus panel. / Cobaugh, Daniel J.; Maynard, Gregory; Cooper, Raymond; Kienle, Patricia C.; Vigersky, Robert; Childers, Diana; Weber, Robert; Carson, Stacy L.; Mabrey, Melanie E.; Roderman, Nicki; Blum, Frederick; Burkholder, Rebecca; Dortch, Marcus; Grunberger, George; Hays, Daniel; Henderson, Rashida; Ketz, Jeffrey; Lemke, Todd; Varma, Surendra K.; Cohen, Michael.

In: American Journal of Health-System Pharmacy, Vol. 70, No. 16, 15.08.2013, p. 1404-1413.

Research output: Contribution to journalArticle

Cobaugh, DJ, Maynard, G, Cooper, R, Kienle, PC, Vigersky, R, Childers, D, Weber, R, Carson, SL, Mabrey, ME, Roderman, N, Blum, F, Burkholder, R, Dortch, M, Grunberger, G, Hays, D, Henderson, R, Ketz, J, Lemke, T, Varma, SK & Cohen, M 2013, 'Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel', American Journal of Health-System Pharmacy, vol. 70, no. 16, pp. 1404-1413. https://doi.org/10.2146/ajhp130169
Cobaugh, Daniel J. ; Maynard, Gregory ; Cooper, Raymond ; Kienle, Patricia C. ; Vigersky, Robert ; Childers, Diana ; Weber, Robert ; Carson, Stacy L. ; Mabrey, Melanie E. ; Roderman, Nicki ; Blum, Frederick ; Burkholder, Rebecca ; Dortch, Marcus ; Grunberger, George ; Hays, Daniel ; Henderson, Rashida ; Ketz, Jeffrey ; Lemke, Todd ; Varma, Surendra K. ; Cohen, Michael. / Enhancing insulin-use safety in hospitals : Practical recommendations from an ASHP Foundation expert consensus panel. In: American Journal of Health-System Pharmacy. 2013 ; Vol. 70, No. 16. pp. 1404-1413.
@article{a0e906ec80e74383b9010e543802c0e5,
title = "Enhancing insulin-use safety in hospitals: Practical recommendations from an ASHP Foundation expert consensus panel",
abstract = "Purpose. Consensus recommendations to help ensure safe insulin use in hospitalized patients are presented. CopyrightSummary. Insulin products are frequently involved in medication errors in hospitals, and insulin is classified as a high-alert medication when used in inpatient settings. In an initiative to promote safer insulin use, the American Society of Health-System Pharmacists (ASHP) Research and Education Foundation convened a 21-member panel representing the fields of pharmacy, medicine, and nursing and consumer advocacy groups for a three-stage consensus-building initiative. The panel's consensus recommendations include the following: development of protocol-driven insulin order sets, elimination of the routine use of correction/sliding-scale insulin doses for management of hyperglycemia, restrictions on the types of insulin products stored in patient care areas, and policies to restrict the preparation of insulin bolus doses and i.v. infusions to the pharmacy department. In addition, the panelists recommended that hospitals better coordinate insulin use with meal intake and glucose testing, prospectively monitor the coordination of insulin delivery and rates of hypoglycemia and hyperglycemia, and provide standardized education and competency assessment for all hospitalbased health care professionals responsible for insulin use.Conclusion. A 21-member expert panel convened by the ASHP Foundation identified 10 recommendations for enhancing insulin-use safety across the medicationuse process in hospitals. Professional organizations, accrediting bodies, and consumer groups can play a critical role in the translation of these recommendations into practice. Rigorous research studies and program evaluations are needed to study the impact of implementation of these recommendations.",
author = "Cobaugh, {Daniel J.} and Gregory Maynard and Raymond Cooper and Kienle, {Patricia C.} and Robert Vigersky and Diana Childers and Robert Weber and Carson, {Stacy L.} and Mabrey, {Melanie E.} and Nicki Roderman and Frederick Blum and Rebecca Burkholder and Marcus Dortch and George Grunberger and Daniel Hays and Rashida Henderson and Jeffrey Ketz and Todd Lemke and Varma, {Surendra K.} and Michael Cohen",
year = "2013",
month = "8",
day = "15",
doi = "10.2146/ajhp130169",
language = "English (US)",
volume = "70",
pages = "1404--1413",
journal = "American Journal of Health-System Pharmacy",
issn = "1079-2082",
publisher = "American Society of Health-Systems Pharmacy",
number = "16",

}

TY - JOUR

T1 - Enhancing insulin-use safety in hospitals

T2 - Practical recommendations from an ASHP Foundation expert consensus panel

AU - Cobaugh, Daniel J.

AU - Maynard, Gregory

AU - Cooper, Raymond

AU - Kienle, Patricia C.

AU - Vigersky, Robert

AU - Childers, Diana

AU - Weber, Robert

AU - Carson, Stacy L.

AU - Mabrey, Melanie E.

AU - Roderman, Nicki

AU - Blum, Frederick

AU - Burkholder, Rebecca

AU - Dortch, Marcus

AU - Grunberger, George

AU - Hays, Daniel

AU - Henderson, Rashida

AU - Ketz, Jeffrey

AU - Lemke, Todd

AU - Varma, Surendra K.

AU - Cohen, Michael

PY - 2013/8/15

Y1 - 2013/8/15

N2 - Purpose. Consensus recommendations to help ensure safe insulin use in hospitalized patients are presented. CopyrightSummary. Insulin products are frequently involved in medication errors in hospitals, and insulin is classified as a high-alert medication when used in inpatient settings. In an initiative to promote safer insulin use, the American Society of Health-System Pharmacists (ASHP) Research and Education Foundation convened a 21-member panel representing the fields of pharmacy, medicine, and nursing and consumer advocacy groups for a three-stage consensus-building initiative. The panel's consensus recommendations include the following: development of protocol-driven insulin order sets, elimination of the routine use of correction/sliding-scale insulin doses for management of hyperglycemia, restrictions on the types of insulin products stored in patient care areas, and policies to restrict the preparation of insulin bolus doses and i.v. infusions to the pharmacy department. In addition, the panelists recommended that hospitals better coordinate insulin use with meal intake and glucose testing, prospectively monitor the coordination of insulin delivery and rates of hypoglycemia and hyperglycemia, and provide standardized education and competency assessment for all hospitalbased health care professionals responsible for insulin use.Conclusion. A 21-member expert panel convened by the ASHP Foundation identified 10 recommendations for enhancing insulin-use safety across the medicationuse process in hospitals. Professional organizations, accrediting bodies, and consumer groups can play a critical role in the translation of these recommendations into practice. Rigorous research studies and program evaluations are needed to study the impact of implementation of these recommendations.

AB - Purpose. Consensus recommendations to help ensure safe insulin use in hospitalized patients are presented. CopyrightSummary. Insulin products are frequently involved in medication errors in hospitals, and insulin is classified as a high-alert medication when used in inpatient settings. In an initiative to promote safer insulin use, the American Society of Health-System Pharmacists (ASHP) Research and Education Foundation convened a 21-member panel representing the fields of pharmacy, medicine, and nursing and consumer advocacy groups for a three-stage consensus-building initiative. The panel's consensus recommendations include the following: development of protocol-driven insulin order sets, elimination of the routine use of correction/sliding-scale insulin doses for management of hyperglycemia, restrictions on the types of insulin products stored in patient care areas, and policies to restrict the preparation of insulin bolus doses and i.v. infusions to the pharmacy department. In addition, the panelists recommended that hospitals better coordinate insulin use with meal intake and glucose testing, prospectively monitor the coordination of insulin delivery and rates of hypoglycemia and hyperglycemia, and provide standardized education and competency assessment for all hospitalbased health care professionals responsible for insulin use.Conclusion. A 21-member expert panel convened by the ASHP Foundation identified 10 recommendations for enhancing insulin-use safety across the medicationuse process in hospitals. Professional organizations, accrediting bodies, and consumer groups can play a critical role in the translation of these recommendations into practice. Rigorous research studies and program evaluations are needed to study the impact of implementation of these recommendations.

UR - http://www.scopus.com/inward/record.url?scp=84886717865&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886717865&partnerID=8YFLogxK

U2 - 10.2146/ajhp130169

DO - 10.2146/ajhp130169

M3 - Article

VL - 70

SP - 1404

EP - 1413

JO - American Journal of Health-System Pharmacy

JF - American Journal of Health-System Pharmacy

SN - 1079-2082

IS - 16

ER -